Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx)

BACKGROUND: In critically ill patients, tigecycline (TGC) remains an important therapeutic option due to its efficacy against multiresistant Gram-positive and Gram-negative bacteria. TGC is metabolized and eliminated predominantly by the liver. Critical illness-induced liver failure may have a profo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Intensive Care
Asıl Yazarlar: Alraish, Rawan, Wicha, Sebastian G., Frey, Otto R., Roehr, Anka C., Pratschke, Johann, Stockmann, Martin, Wuensch, Tilo, Kaffarnik, Magnus
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7403243/
https://ncbi.nlm.nih.gov/pubmed/32754775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13613-020-00707-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller